FRIEDMAN INDUSTRIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FRIEDMAN INDUSTRIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Mar 31, 2018 | $43.96M | Jun 28, 2018 |
| FY2017 | Dec 31, 2017 | $28.03M | Jun 28, 2018 |
| FY2017 | Sep 30, 2017 | $26.08M | Jun 28, 2018 |
| FY2017 | Jun 30, 2017 | $23.08M | Jun 28, 2018 |
| FY2017 | Mar 31, 2017 | $21.06M | Jun 28, 2018 |
| FY2017 | Dec 31, 2016 | $15.99M | Jun 28, 2018 |
| FY2017 | Sep 30, 2016 | $18.32M | Jun 28, 2018 |
| FY2017 | Jun 30, 2016 | $22.39M | Jun 28, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Mar 31, 2021 | $17.74M | Jul 7, 2021 |
| FY2021 | Dec 31, 2020 | $4.50M | Jul 7, 2021 |
| FY2021 | Sep 30, 2020 | $1.09M | Jul 7, 2021 |
| FY2021 | Jun 30, 2020 | $256.8K | Jul 7, 2021 |
| FY2021 | Mar 31, 2020 | $1.87M | Jul 7, 2021 |
| FY2021 | Dec 31, 2019 | $52.9K | Jul 7, 2021 |
| FY2021 | Sep 30, 2019 | ($782.7K) | Jul 7, 2021 |
| FY2021 | Jun 30, 2019 | $1.47M | Jul 7, 2021 |
| FY2019 | Mar 31, 2019 | $839.5K | Jun 30, 2020 |
| FY2019 | Dec 31, 2018 | $1.93M | Jun 30, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $6.09M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $17.35M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $21.34M | Jun 11, 2024 |
| FY2023 | Mar 31, 2022 | $14.07M | Jul 14, 2023 |
| FY2021 | Mar 31, 2021 | $10.40M | Jul 7, 2021 |
| FY2021 | Dec 31, 2020 | $2.13M | Jul 7, 2021 |
| FY2021 | Sep 30, 2020 | ($250.0K) | Jul 7, 2021 |
| FY2021 | Jun 30, 2020 | ($858.9K) | Jul 7, 2021 |
| FY2021 | Mar 31, 2020 | ($3.02M) | Jul 7, 2021 |
| FY2021 | Dec 31, 2019 | ($881.0K) | Jul 7, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $3.04M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $24.52M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $21.07M | Jun 11, 2024 |
| FY2023 | Mar 31, 2022 | $28.52M | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $15.73M | Aug 2, 2022 |
| FY2021 | Mar 31, 2020 | ($6.86M) | Jul 7, 2021 |
| FY2019 | Mar 31, 2019 | $6.38M | Jun 30, 2020 |
| FY2018 | Mar 31, 2018 | $5.74M | Jul 1, 2019 |
| FY2017 | Mar 31, 2017 | ($4.21M) | Jun 28, 2018 |
| FY2016 | Mar 31, 2016 | $23.4K | Jun 29, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $16.17M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $21.04M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $21.89M | Jun 11, 2024 |
| FY2023 | Mar 31, 2022 | $12.47M | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $7.84M | Aug 2, 2022 |
| FY2021 | Mar 31, 2020 | $5.12M | Jul 7, 2021 |
| FY2019 | Mar 31, 2019 | $4.78M | Jun 30, 2020 |
| FY2018 | Mar 31, 2018 | $4.18M | Jul 1, 2019 |
| FY2017 | Mar 31, 2017 | $4.02M | Jun 28, 2018 |
| FY2016 | Mar 31, 2016 | $4.67M | Jun 29, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($4.41M) | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $4.98M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $63.89M | Jun 11, 2024 |
| FY2023 | Mar 31, 2022 | ($13.40M) | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $8.43M | Aug 2, 2022 |
| FY2021 | Mar 31, 2020 | $11.23M | Jul 7, 2021 |
| FY2019 | Mar 31, 2019 | $9.63M | Jun 30, 2020 |
| FY2018 | Mar 31, 2018 | $3.25M | Jul 1, 2019 |
| FY2017 | Mar 31, 2017 | ($202.7K) | Jun 28, 2018 |
| FY2012 | Mar 31, 2013 | $11.50M | Jun 13, 2013 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $4.00M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $5.79M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $16.45M | Jun 11, 2024 |
| FY2023 | Mar 31, 2022 | $8.07M | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $4.61M | Aug 2, 2022 |
| FY2021 | Mar 31, 2020 | $4.94M | Jul 7, 2021 |
| FY2019 | Mar 31, 2019 | $808.0K | Jun 30, 2020 |
| FY2018 | Mar 31, 2018 | $349.2K | Jul 1, 2019 |
| FY2017 | Mar 31, 2017 | $799.3K | Jun 28, 2018 |
| FY2016 | Mar 31, 2016 | $2.12M | Jun 29, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $226.82M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $230.02M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $199.31M | Jun 11, 2024 |
| FY2023 | Mar 31, 2022 | $159.28M | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $95.01M | Aug 2, 2022 |
| FY2021 | Mar 31, 2020 | $77.34M | Jul 7, 2021 |
| FY2019 | Mar 31, 2019 | $86.60M | Jun 30, 2020 |
| FY2018 | Mar 31, 2018 | $81.65M | Jul 1, 2019 |
| FY2017 | Mar 31, 2017 | $63.26M | Jun 28, 2018 |
| FY2016 | Mar 31, 2016 | $66.89M | Jun 29, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $94.40M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $102.54M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $83.88M | Jun 11, 2024 |
| FY2023 | Mar 31, 2022 | $79.59M | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $29.67M | Aug 2, 2022 |
| FY2021 | Mar 31, 2020 | $10.48M | Jul 7, 2021 |
| FY2019 | Mar 31, 2019 | $14.12M | Jun 30, 2020 |
| FY2018 | Mar 31, 2018 | $13.08M | Jul 1, 2019 |
| FY2017 | Mar 31, 2017 | $2.91M | Jun 28, 2018 |
| FY2016 | Mar 31, 2016 | $3.65M | Jun 29, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $132.43M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $127.48M | Jun 12, 2025 |
| FY2025 | Mar 31, 2023 | $115.43M | Jun 12, 2025 |
| FY2024 | Mar 31, 2022 | $79.69M | Jun 11, 2024 |
| FY2023 | Mar 31, 2021 | $65.34M | Jul 14, 2023 |
| FY2022 | Mar 31, 2020 | $66.87M | Aug 2, 2022 |
| FY2021 | Mar 31, 2019 | $72.48M | Jul 7, 2021 |
| FY2018 | Mar 31, 2018 | $68.58M | Jul 1, 2019 |
| FY2017 | Mar 31, 2017 | $60.36M | Jun 28, 2018 |
| FY2016 | Mar 31, 2016 | $63.24M | Jun 29, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $101.25M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $96.28M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $79.65M | Jun 11, 2024 |
| FY2023 | Mar 31, 2022 | $58.91M | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $45.39M | Aug 2, 2022 |
| FY2021 | Mar 31, 2020 | $34.53M | Jul 7, 2021 |
| FY2019 | Mar 31, 2019 | $40.48M | Jun 30, 2020 |
| FY2018 | Mar 31, 2018 | $36.71M | Jul 1, 2019 |
| FY2017 | Mar 31, 2017 | $28.78M | Jun 28, 2018 |
| FY2016 | Mar 31, 2016 | $31.74M | Jun 29, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $3.69M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $2.89M | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $2.99M | Jun 11, 2024 |
| FY2023 | Mar 31, 2022 | $2.60M | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $8.19M | Aug 2, 2022 |
| FY2021 | Mar 31, 2020 | $17.06M | Jul 7, 2021 |
| FY2019 | Mar 31, 2019 | $11.67M | Jun 30, 2020 |
| FY2019 | Mar 31, 2018 | $4.05M | Jun 30, 2020 |
| FY2018 | Mar 31, 2017 | $1.46M | Jul 1, 2019 |
| FY2017 | Mar 31, 2016 | $2.80M | Jun 28, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | 2 | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | 2 | Jun 11, 2024 |
| FY2023 | Mar 31, 2022 | 2 | Jul 14, 2023 |
| FY2021 | Mar 31, 2021 | 1 | Jul 7, 2021 |
| FY2021 | Dec 31, 2020 | 0 | Jul 7, 2021 |
| FY2021 | Sep 30, 2020 | 0 | Jul 7, 2021 |
| FY2021 | Jun 30, 2020 | 0 | Jul 7, 2021 |
| FY2021 | Mar 31, 2020 | 0 | Jul 7, 2021 |
| FY2021 | Dec 31, 2019 | 0 | Jul 7, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | 2 | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | 2 | Jun 11, 2024 |
| FY2023 | Mar 31, 2022 | 2 | Jul 14, 2023 |
| FY2021 | Mar 31, 2021 | 1 | Jul 7, 2021 |
| FY2021 | Dec 31, 2020 | 0 | Jul 7, 2021 |
| FY2021 | Sep 30, 2020 | 0 | Jul 7, 2021 |
| FY2021 | Jun 30, 2020 | 0 | Jul 7, 2021 |
| FY2021 | Mar 31, 2020 | 0 | Jul 7, 2021 |
| FY2021 | Dec 31, 2019 | 0 | Jul 7, 2021 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.12M | Jun 12, 2025 |
| FY2025 | Mar 31, 2024 | $581.0K | Jun 12, 2025 |
| FY2024 | Mar 31, 2023 | $589.0K | Jun 11, 2024 |
| FY2023 | Mar 31, 2022 | $551.0K | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $564.2K | Aug 2, 2022 |
| FY2021 | Mar 31, 2020 | $839.9K | Jul 7, 2021 |
| FY2019 | Mar 31, 2019 | $1.19M | Jun 30, 2020 |
| FY2018 | Mar 31, 2018 | $280.4K | Jul 1, 2019 |
| FY2017 | Mar 31, 2017 | $274.1K | Jun 28, 2018 |
| FY2016 | Mar 31, 2016 | $272.0K | Jun 29, 2017 |